The financials
Teleflex Incorporated by the numbers
Teleflex Incorporated (TFX) reported revenue of $570M in Q2 2026 (quarter ended June 30, 2026), up 29% from the same quarter a year earlier. That came with a gross margin of 58% and net income of $100M (17% of revenue). For the full year FY2025, revenue was $1.99B (+17% year on year) and net income −$906M. Its largest product in 2026-Q1 was Vascular Access at $237M, 43% of the disclosed total, just ahead of Interventional at 37%.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $570M | $443M | +29% |
| Gross profit | $332M | $266M | +25% |
| Operating income | $73M | $91M | −20% |
| Net income | $100M | $123M | −19% |
| Diluted EPS | $2.28 | $2.77 | −18% |
| Product | Revenue | Share |
|---|---|---|
| Vascular Access | $237M | 43% |
| Interventional | $205M | 37% |
| Surgical | $107M | 19% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q1 2026Total $548.3M (-40%)
Interventional grew +104% year on yearVascular Access +8.1% year on year
Segment Latestquarter on quarteryear on year
- Vascular Access$236.8M$236.8MQoQ +24%year on year +8.1%+24%+8.1%
- Interventional$204.7M$204.7MQoQ -23%year on year +104%-23%+104%
- Surgical$106.8M$106.8MQoQ -13%year on year +12%-13%+12%
- Anesthesia--QoQ -year on year ---
- Interventional Urology--QoQ -year on year ---
- Oem--QoQ -year on year ---
- Other--QoQ -year on year ---
Medical Instruments & Supplies
Ranks #12 of 27 by Smart Score